KNSA · All filings · Read this filing
What changed 10-K
Item 2. Properties
2023-03-02 compared with 2022-02-24 · 1 added, 1 removed, 7 unchanged (22% of the section changed)
2 unchanged sentences
Further, Kiniksa Pharmaceuticals (UK), Ltd., our wholly owned subsidiary (“Kiniksa UK”), has leased approximately 164 square meters of office space in London, UK which expires in November 2025 with an option for early termination in November 2023.
−Removed: We believe that our offices are sufficient to meet our current needs and that suitable additional space will be available as and when needed.
+Added: While we believe that our offices are sufficient to meet our current needs, we may in the future seek office space in the US or internationally to facilitate our operations.
LEGAL PROCEEDINGS.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.